New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Bowel Movement Frequency Is Not Linked With Cognitive Function in Cirrhosis.
Bowel Movement Frequency Is Not Linked With Cognitive Function in Cirrhosis. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association Duong, N., Reuter, B., Saraireh, H., Nadhem, O., Acharya, C., Fagan, A., Hassouneh, R., Bajaj, J. S. 2022; 20 (4): e897-e901Abstract
The spectrum of hepatic encephalopathy (HE) ranges from overt HE (OHE) to cognitive impairment (ie, covert) HE (CHE).1 The first-line therapy is lactulose, which is titrated to achieve ~2-3 soft/loose daily bowel movements (BM). This metric is considered dogma for practitioners despite erratic results, GI adverse events, and poor tolerance in Western countries.1 There are logistic barriers for the widespread uptake of rifaximin, the second-line therapy. Moreover, although BM frequency-directed dose titration of lactulose is the usual practice, its impact on objective cognitive performance is unclear. Our aim is to determine the impact of BM frequency on cognition in patients with/without prior OHE.
View details for DOI 10.1016/j.cgh.2021.05.014
View details for PubMedID 33991690
View details for PubMedCentralID PMC8589867